| Debra Ann Stumpf Hollister, DO | |
|
3530 Houma Blvd Ste 300, Metairie, LA 70006 | |
| (504) 264-5142 | |
| (504) 455-2648 |
| Full Name | Debra Ann Stumpf Hollister |
|---|---|
| Gender | Female |
| Speciality | Family Medicine |
| Location | 3530 Houma Blvd Ste 300, Metairie, Louisiana |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1124023643 | NPI | - | NPPES |
| 2195851 | Medicaid | OH |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 34-00-7136-H (Ohio) | Secondary |
| 207Q00000X | Family Medicine | DO.000130 (Louisiana) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Debra Ann Stumpf Hollister, DO 1395 Nw 167th St, Miami, FL 33169-5710 Ph: (504) 264-5142 | Debra Ann Stumpf Hollister, DO 3530 Houma Blvd Ste 300, Metairie, LA 70006 Ph: (504) 264-5142 |
News Archive
Nu Skin Enterprises, Inc. today announced record second-quarter results with revenue of $682.9 million, a 15 percent increase over the prior-year period. Revenue for the quarter was negatively impacted 3 percent by foreign currency fluctuations. Quarterly earnings per share increased 30 percent to $1.22 from $0.94 in the prior year.
Fluidigm Corporation today introduced its reusable FR48.48 Dynamic Array™ integrated fluidic circuit (IFC) - the world's first reusable bio-chip for the SNP genotyping market. This chip begins a new era of ultra-low cost, high sample throughput SNP genotyping and marks the beginning of Fluidigm's drive toward one-penny-per-data point.
ICF International, a leading provider of consulting services and technology solutions to government and commercial clients, has been awarded a $31.8 million re-compete contract by the U.S. Food and Drug Administration to provide information technology and scientific support services to the National Center for Toxicological Research.
ARCA biopharma, Inc. today announced its planned next steps in response to the May 29, 2009 Complete Response Letter (CRL) from the U.S. Food and Drug Administration (FDA) for ARCA's New Drug Application (NDA) seeking approval for GencaroTM (bucindolol hydrochloride) for the treatment of patients with chronic heart failure. Following receipt of the CRL, the Company and the FDA have held a series of meetings to discuss how best to address the requirements identified in the CRL.
The innate immune system comprises of various soluble factors that provide the first line of defense against pathogens.
› Verified 6 days ago
Ka-yan Tong, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 4509 Shores Dr, Metairie, LA 70006 Phone: 504-885-2535 | |
Joseph Michael Fazio, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 206 Sierra Ct, Metairie, LA 70001 Phone: 504-834-1311 Fax: 504-834-1329 | |
Dr. Richard Edward Bridges, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 4228 Houma Blvd, Ste 200, Metairie, LA 70006 Phone: 504-454-7878 Fax: 504-883-3775 | |
Charles Joseph Cucchiara, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 4228 Houma Blvd, Ste 200, Metairie, LA 70006 Phone: 504-454-7878 Fax: 504-883-3775 | |
Dr. Michelle Mireille Davis, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 4224 Houma Blvd Ste 350, Metairie, LA 70006 Phone: 504-780-9112 Fax: 314-536-8784 | |
Sammy Motia Okole, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 5500 Veterans Blvd. Suite 208, Metairie, LA 70003 Phone: 504-887-7792 Fax: 504-240-9000 | |
Jonathon Sossamon, Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 4228 Houma Blvd, Ste. 230, Metairie, LA 70006 Phone: 504-503-6206 |